Demazin is a well-known, pharmacy only brand, that has been a staple of Australian medicine cabinets for over 50 years. Despite strong success for many decades, ownership changes in more recent years caused Demazin to suffer significant sales decline due to a lack of focus and support.
When iNova acquired Demazin from Bayer in 2019, we did so with the intention to revitalise the brand and restore it to its former glory. In just over 12 months the Australian team developed a revised brand strategy, created four new Demazin products to fill gaps in the range, developed new-look packaging to refresh the brand and launched it back into market with a fresh and fun television advertising campaign featuring the old favourite ‘D-D-Demazin’ mnemonic.
With iNova’s strong investment, distribution reach and strong pharmacy relationships, we are confident Demazin will grow to again be the ‘go-to’ brand for the whole family.
Demazin is exactly the type of brand that iNova looks to own or distribute – a proven and effective product with an established reputation among healthcare professionals and consumers, that, with a bit of investment and focus, has the potential to grow.
Our door is always open to prospective vendors and business partners here at iNova Pharmaceuticals!